Drug Recall: Artificial Tears Eye Ointment Due to Manufacturing Deviations
Akorn, Inc. is recalling Artificial Tears Ointment (1.16 million tubes nationwide) due to manufacturing practice deviations. The firm voluntarily initiated this recall.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations affecting a sterile eye ointment—a risk-of-harm product where manufacturing deviations may compromise the sterility assurance critical for safe ophthalmic use.
Plain-English summary
Akorn, Inc. is recalling Artificial Tears Ointment, a sterile lubricant eye ointment, due to manufacturing process deviations. Approximately 1,164,171 tubes with various expiration dates from 2022 through 2024 were distributed nationwide.
The recall was initiated after the manufacturer discovered deviations from Current Good Manufacturing Practice (CGMP) standards. These deviations may affect the product's sterility and quality assurance.
The affected product was distributed nationwide in the United States. Consumers using the recalled product should discontinue use and consult their healthcare provider with any health concerns. The FDA maintains a complete list of affected lot numbers and expiration dates.
The recalled product
- Product
- Artificial Tears OINTMENT, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) per tube, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-062-35
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic / Eye Ointment
- Hazard
- manufacturing-defect
- sterility-concern
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 0A08B
- EXP 12/31/2022
- 0B63A
- EXP 1/31/2023
- 0C72A
- EXP 2/28/2023
- 0D14A
- 0D19A
- EXP 3/31/2023
- 0F54A
- EXP 5/31/2023
- 0G80B
- 0G09B
- 0G97A
- EXP 6/30/2023
- 0J78A
- EXP 8/31/2023
- 0K23A
- EXP 9/30/2023
- 0L64A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27